Sedivention





Devices for therapy and prevention

Invented in Bavaria

Our Partners and Supporters

We work internationally with experts in engineering, regulatory, and clinical.

Medicine is our passion

With a long and intense experience in clinical practise, we know where the medical need is.
With our devices, we aim to address these needs and make therapy less invasive. 

Ute Nollert, MD, founder of Sedivention experienced the whole spectrum of anesthesiology from liver transplant and ICU to cardiac surgery and dental interventions. The setting was international from university hospitals to ambulatory care.  

The Team

André Burch MSc, EMBA 

28+ years in global leading medical device companies  

Board of Directors, VP Finance & Admin at BIOTRONIK Vascular Intervention

VP Clinical/Regulatory Affairs, VP New Businesses (startup approach)

Director R&D at BIOTRONIK VI

Director R&D, Boston Scientific and Pfizer/Schneider Worldwide

ETH Zurich / IMD Lausanne, Switzerland

Ute Nollert, MD

Consultant in anaesthesia at the University of Munich,  LMU for 13 years

European Diploma in Anaesthesiology and Intensive Care

Author o f numerous scientific articles and textbook chapters in particular ambulant anesthesia and conscious sedation

Consultant Sana Klinik, Munich, Germany

Stéphane Delaloye,
PhD, EMBA

25+ years in medical device industry, numerous key patents granted

COO/VP R&D, Symetis AG – from start to successful exit in 2017

Director R&D, Biotronik AG

Manager R&D, Boston Scientific

Manager R&D, Pfizer/Schneider WW

ETH Zurich / HSG St. Gallen, Switzerland